Medicinal Plant Research 2025, Vol.15, No.3, 110-118 http://hortherbpublisher.com/index.php/mpr 118 Swallah M., Bondzie-Quaye P., Wu Y., Acheampong A., Sossah F., Elsherbiny S., and Huang Q., 2023, Therapeutic potential and nutritional significance of Ganoderma lucidum: a comprehensive review from 2010 to 2022, Food and Function, 14(2): 647-665. https://doi.org/10.1039/d2fo01683d Wang S., Wang L., Shangguan J., Jiang A., and Ren A., 2024, Research progress on the biological activity of ganoderic acids in Ganoderma lucidum over the last five years, Life, 14(10): 1339. https://doi.org/10.3390/life14101339 Wu S., Zhang S., Peng B., Tan D., Wu M., Luo H., Wei J., and Wang Y., 2023, Ganoderma lucidum: a comprehensive review of phytochemistry, efficacy, safety and clinical study, Food Science and Human Wellness. https://doi.org/10.26599/fshw.2022.9250051 Xia L., Sun R., Zhang L., Li J., Zhang C., Yang Q., Zhang L., Zhang S., Wang H., Lyu H., Lyu W., Li Z., and Zhang L., 2023, A 26-week repeated dose toxicity evaluation of sporoderm-removed Ganoderma lucidum spores in rats, Food and Chemical Toxicology, 114175. https://doi.org/10.1016/j.fct.2023.114175 Ye D., Zhao Q., Ding D., and B., 2023, Preclinical pharmacokinetics-related pharmacological effects of orally administered polysaccharides from traditional Chinese medicines: a review, International Journal of Biological Macromolecules, 126484. https://doi.org/10.1016/j.ijbiomac.2023.126484 Zeng P., Guo Z., Zeng X., Hao C., Zhang Y., Zhang M., Liu Y., Li H., Li J., and Zhang L., 2018, Chemical, biochemical, preclinical and clinical studies of Ganoderma lucidum polysaccharide as an approved drug for treating myopathy and other diseases in China, Journal of Cellular and Molecular Medicine, 22(6): 3278-3297. https://doi.org/10.1111/jcmm.13613 Zhang X., 2024, Breeding high-yield and disease-resistant carrot varieties using marker-assisted selection, International Journal of Horticulture, 14(4): 263-274. https://doi.org/10.5376/ijh.2024.14.0028
RkJQdWJsaXNoZXIy MjQ4ODYzNA==